Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001832332
Market Cap 1.73 Bn
P/B 188.33
P/E 22.92
P/S 0.76
ROIC (Qtr) 16.16
Div Yield % 0.00
Rev 1y % (Qtr) 22.18
Total Debt (Qtr) 1.51 Bn
Debt/Equity (Qtr) 164.42

About

Aveanna Healthcare Holdings, Inc., or simply Aveanna, operates in the healthcare industry with the ticker symbol AVAH. The company is a leading diversified home care platform, providing care to medically complex, high-cost patient populations. Its main business activities encompass a range of home care services, including private duty nursing, pediatric therapy, home health, hospice, and medical solutions. Aveanna's operations span across various regions, generating revenue through three primary segments. The Private Duty Services (PDS) segment...

Read more

Price action

Investment thesis

Bull case

  • Robust free cash flow of 82.52M exceeds capital expenditure of 7.03M by 11.75x, indicating strong organic growth funding capability.
  • Robust tangible asset base of 600.22M provides 6.46x coverage of working capital 92.91M, indicating strong operational backing.
  • Operating cash flow of 89.54M fully covers other non-current liabilities 74.96M by 1.19x, showing strong long-term stability.
  • Cash reserves of 145.87M provide solid 1.95x coverage of other non-current liabilities 74.96M, indicating strong liquidity.
  • Operating cash flow of 89.54M provides strong 13.77x coverage of tax liabilities 6.50M, showing excellent fiscal position.

Bear case

  • Operating cash flow of 89.54M barely covers its investment activities of (21.88M), with a coverage ratio of -4.09, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Cash reserves of 145.87M provide limited coverage of acquisition spending of (14.85M), which is -9.82x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • The company's operating cash flow of 89.54M shows concerning coverage of stock compensation expenses of 26.10M, with a 3.43 ratio indicating potential earnings quality issues.
  • Free cash flow of 82.52M represents just -7.58x of debt issuance (10.89M), suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • R&D investment of 0 represents just 0x of SG&A expenses of 523.05M, indicating potential underinvestment in innovation relative to administrative overhead.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.72 1.26
EV to Cash from Ops. EV/CFO 34.82 12.78
EV to Debt EV to Debt 2.06 12.10
EV to EBIT EV/EBIT 12.98 10.74
EV to EBITDA EV/EBITDA 12.02 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 37.79 18.02
EV to Market Cap EV to Market Cap 1.80 432.64
EV to Revenue EV/Rev 1.36 2.77
Price to Book Value [P/B] P/B 188.12 -1.92
Price to Earnings [P/E] P/E 22.89 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) 1.65 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -10.49 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 85.91 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 48.45 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 68.05 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) 129.31 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) 277.03 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) 208.57 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 736.22 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 25.58 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.27 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.36 0.39
Current Ratio Curr Ratio (Qtr) 1.23 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 164.42 -13.19
Interest Cover Ratio Int Coverage (Qtr) 1.65 -97.94
Times Interest Earned Times Interest Earned (Qtr) 1.65 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 11.70 -95.81
EBIT Margin % EBIT Margin % (Qtr) 10.49 -94.97
EBT Margin % EBT Margin % (Qtr) 4.13 -105.60
Gross Margin % Gross Margin % (Qtr) 33.60 23.31
Net Profit Margin % Net Margin % (Qtr) 3.30 -106.14